Success Metrics

Clinical Success Rate
86.7%

Based on 13 completed trials

Completion Rate
87%(13/15)
Active Trials
7(27%)
Results Posted
15%(2 trials)
Terminated
2(8%)

Phase Distribution

Ph phase_1
3
12%
Ph not_applicable
13
50%
Ph phase_2
5
19%

Phase Distribution

3

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
3(14.3%)
Phase 2Efficacy & side effects
5(23.8%)
N/ANon-phased studies
13(61.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

86.7%

13 of 15 finished

Non-Completion Rate

13.3%

2 ended early

Currently Active

7

trials recruiting

Total Trials

26

all time

Status Distribution
Active(7)
Completed(13)
Terminated(2)
Other(4)

Detailed Status

Completed13
Recruiting7
unknown4
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
26
Active
7
Success Rate
86.7%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (14.3%)
Phase 25 (23.8%)
N/A13 (61.9%)

Trials by Status

recruiting727%
terminated28%
completed1350%
unknown415%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT06620835Phase 2

Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib

Recruiting
NCT05524311Phase 2

Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)

Completed
NCT02780128Phase 1

Next Generation Personalized Neuroblastoma Therapy

Terminated
NCT06815939Not Applicable

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Recruiting
NCT06747598

Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing

Completed
NCT06737380Phase 1

UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients

Recruiting
NCT05042830Not Applicable

Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact

Recruiting
NCT05009758Not Applicable

Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps

Recruiting
NCT00949481Not Applicable

Increasing Family Planning Uptake Among Postpartum Women

Completed
NCT06676410Phase 2

Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants

Recruiting
NCT05454462Phase 1

KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)

Completed
NCT05648929Not Applicable

Experimental and Clinical Investigation of the Implant Surface Roughness Reduction Effect on Early-stage Fibrosis

Completed
NCT03299179

The Effects of the Female Hormones on Cerebral Perfusion

Recruiting
NCT03273972Not Applicable

INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers

Completed
NCT05037162Phase 2

Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Completed
NCT04824118

Clotting Parameters After Medical Abortion

Completed
NCT03713736Not Applicable

Papillomavirus Load in Rheumatic Inflammatory Diseases

Unknown
NCT02901080Not Applicable

Clinical and Cost Effectiveness of Alpha-Stim AID CES

Completed
NCT02967315Not Applicable

Effects of Changes in Fluid Status on Right Ventricular Volumes and Function

Completed
NCT03291821Not Applicable

DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore

Completed

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
26